The Motley Fool·May 1·Sarah SidlowPacira CFO Offloads $326K in Stock Ahead of Strong Q1 ResultsPacira CFO sold $326K in stock via pre-planned trading arrangement before Q1 earnings beat, with shares appreciating 12% in April. PCRXQ1 earningspharmaceutical company
The Motley Fool·Apr 3·Robert IzquierdoAAR Executive's $705K Stock Sale Masks Strong Fundamentals as Stock Hits 52-Week HighAAR Corp.'s senior VP sold $705K in shares, but routine option exercise. Strong Q3 results drive stock near 52-week highs. AIRvaluationinsider sale
The Motley Fool·Mar 31·Seena HassounaAdaptive Biotech President Sells $1.2M in Stock, But Bullish Stance Remains IntactAdaptive Biotechnologies' president sold $1.21M in shares via pre-planned transaction, yet retains substantial holdings. Stock up 51% annually as core MRD business surges. ADPTbiotechnologyinsider sale
The Motley Fool·Mar 1·Adé HennisSeacoast Banking EVP Sells $416K in Shares Amid Mixed SignalsSeacoast Banking EVP sells $416K in shares despite company's seven quarters of revenue growth and $4.4B acquisition. Stock down 13.44% in five years amid geographic concentration concerns. SBCFacquisitionrevenue growth
The Motley Fool·Feb 16·Adé HennisKirby Corporation Executive Unloads $662K in Stock Following Options ExerciseKirby Corporation VP Ronald Dragg sold $662K in stock after exercising options, reducing his stake 34.30%. Company maintains strong operational performance. KEXearnings beatinsider trading